BEAM

Brain-Eye Amyloid Memory (BEAM) Study – What if changes to the eye could be used to diagnose dementia earlier?
The Brain-Eye Amyloid Memory (BEAM) study is investigating whether measurements of the eye can be used with other tests to detect dementia earlier.  By comparing the results of non-invasive tests similar to those done in an eye doctor’s office with established tests of cognition, magnetic resonance imaging (MRI) and a positron emission tomography (PET) scan, researchers can look for links between changes in parts of the eye in dementia.  PET scans can detect amyloid that has deposited in the brain, which is a hallmark of Alzheimer’s disease. More details on the BEAM Study.

Sites:

  • Baycrest
  • Centre for Addiction and Mental Health
  • St. Michael’s Hospital
  • Sunnybrook Health Sciences Centre
  • University Health Network (UHN)
  • University of Toronto

Affiliates:

  • Center for Probe Development and Commercialization
  • Kensington Eye Institute

Principal Investigator:
Dr. Sandra Black

Co-investigators:
Dr. Tiffany Chow, Dr. Sherif El Defrawy, Dr. Corinne Fischer, Dr. Morris Freedman, Dr. Barry Greenberg, Dr. Nathan Herrmann, Dr. Sylvain Houle, Dr. Christopher Hudson, Dr. Peter Kertes, Dr. Alexander Kiss, Dr. Sanjeev Kumar, Dr. Anthony E. Lang, Dr. Efrem Mandelcorn, Dr. Edward Margolin, Dr. Mario Masellis, Dr. William McIlroy, Dr. Ur Metser, Dr. Doug Munoz, Dr. Bruce Pollock, Dr. Tarek Rajji, Dr. Ekaterina Rogaeva, Dr. Stephen Strother, Dr. Don Stuss, Dr. Richard Swartz, Dr. David Tang-Wai, Dr. Carmela Tartaglia, Dr. John Valliant, Dr. Aristotle Voineskos, Dr. Victor Yang, Dr. Katherine Zukotynski

 

Click here for more information on the BEAM study.